May 22, 2020Frontiers in Medicine91 citationsOpen Access

Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia

UMUrsula MirastschijskiGender Studies RDRolf DembinskiKlinikum Bremen-Mitte KMKathrin MaedlerUniversity of Bremen

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Citation: Mirastschijski U, Dembinski R and Maedler K (2020) Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia. Front. Med. 7:254. doi: 10.3389/fmed.2020.00254

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Mirastschijski et al. (Fri,) studied this question.

synapsesocial.com/papers/6a0daef91e1a6dfdb4babe74 https://doi.org/https://doi.org/10.3389/fmed.2020.00254

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?2020 · 3,061 citations
2A pneumonia outbreak associated with a new coronavirus of probable bat origin2020 · 23,430 citations
3The “wisdom” of lung surfactant: balancing host defense and surface tension-reducing functions2006 · 22 citations
4Critical Care Medicine: Principles of Diagnosis and Management in the Adult2002 · 160 citations
5SFTA2—A Novel Secretory Peptide Highly Expressed in the Lung—Is Modulated by Lipopolysaccharide but Not Hyperoxia2012 · 25 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo